Effects of triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy on glucose metabolism in cystic fibrosis patients

被引：0
|
作者：
Yesquen, Pamela [1 ]
Campos, Ariadna [1 ]
Mogas, Eduard [1 ]
Yeste, Diego [1 ]
Gartnet, Silvia [1 ]
Clemente, Maria [1 ]
机构：
[1] Vall Hebron Univ Hosp, Barcelona, Spain
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2023年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1-433
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [1] Effects of cystic fibrosis transmembrane conductance regulator (CFTR)-modulating therapy on glucose metabolism in cystic fibrosis patients
    Yesquen, Pamela
    Campos, Ariadna
    Mogas, Eduard
    Yeste, Diego
    Gartner, Silvia
    Clemente, Maria
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 179 - 179
  • [2] A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
    Zaher, Anas
    ElSaygh, Jude
    Elsori, Dalal
    ElSaygh, Hassan
    Sanni, Abdulsabar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [3] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Parisi, Giuseppe Fabio
    Mollica, Federico
    Giallongo, Alessandro
    Papale, Maria
    Manti, Sara
    Leonardi, Salvatore
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2022, 23 (01)
  • [4] The effect of triple therapy cystic fibrosis transmembrane conductance regulator (CFTR) modulation on anxiety in people with cystic fibrosis
    O'Carroll, O.
    McKeown, C.
    Bell, J.
    Nicholson, T.
    Gallagher, C.
    McKone, E.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
    Giuseppe Fabio Parisi
    Federico Mòllica
    Alessandro Giallongo
    Maria Papale
    Sara Manti
    Salvatore Leonardi
    Egyptian Journal of Medical Human Genetics, 23
  • [6] Cystic Fibrosis Foundation Pulmonary Guidelines Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis
    Ren, Clement L.
    Morgan, Rebecca L.
    Oermann, Christopher
    Resnick, Helaine E.
    Brady, Cynthia
    Campbell, Annette
    DeNagel, Richard
    Guill, Margaret
    Hoag, Jeffrey
    Lipton, Andrew
    Newton, Thomas
    Peters, Stacy
    Willey-Courand, Donna Beth
    Naureckas, Edward T.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (03) : 271 - 280
  • [7] Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients
    Bruch, Brittany A.
    Singh, Sachinkumar B.
    Ramsey, Laura J.
    Starner, Timothy D.
    PEDIATRIC PULMONOLOGY, 2018, 53 (08) : 1035 - 1039
  • [8] CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR)
    HIGGINS, CF
    BRITISH MEDICAL BULLETIN, 1992, 48 (04) : 754 - 765
  • [9] Pharmacology of CFTR (cystic fibrosis transmembrane conductance regulator)
    Cuthbert, A. W.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 22 - 22
  • [10] Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators
    Vargas-Roldan, Silvia Y.
    Lezana-Fernandez, Jose L.
    Cerna-Cortes, Jorge F.
    Partida-Sanchez, Santiago
    Santos-Preciado, Jose, I
    Rosales-Reyes, Roberto
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2022, 79 (04): : 215 - 221
12345